Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment
- PMID: 26481491
- DOI: 10.1007/s00436-015-4760-0
Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment
Abstract
Blastocystis sp., an intestinal organism is known to cause diarrhea with metronidazole regarded as the first line of treatment despite reports of its resistance. The conflicting reports of variation in drug treatment have been ascribed to subtype differences. The present study evaluated in vitro responses due to metronidazole on ST3 isolated from three symptomatic and asymptomatic patients, respectively. Symptomatic isolates were obtained from clinical patients who showed symptoms such as diarrhea and abdominal bloating. Asymptomatic isolates from a stool survey carried out in a rural area. These patients had no other pathogens other than Blastocystis. Ultrastructural studies using transmission electron microscopy (TEM) and scanning electron microscopy (SEM) revealed drug-treated ST3 from symptomatic patients were irregular and amoebic with surface showing high-convoluted folding when treated with metronidazole. These organisms had higher number of mitochondrion-like organelle (MLO) with prominent cristae. However, the drug-treated ST3 from asymptomatic persons remained spherical in shape. Asymptomatic ST3 showed increase in the size of its central body with the MLO located at the periphery.
Keywords: Amoeboid; Asymptomatic; Blastocystis; Metronidazole; Subtype 3; Symptomatic.
Similar articles
-
Apoptosis in Blastocystis spp. is related to subtype.Trans R Soc Trop Med Hyg. 2012 Dec;106(12):725-30. doi: 10.1016/j.trstmh.2012.08.005. Epub 2012 Nov 8. Trans R Soc Trop Med Hyg. 2012. PMID: 23141370
-
Granular Formation during Apoptosis in Blastocystis sp. Exposed to Metronidazole (MTZ).PLoS One. 2016 Jul 29;11(7):e0155390. doi: 10.1371/journal.pone.0155390. eCollection 2016. PLoS One. 2016. PMID: 27471855 Free PMC article.
-
Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.Parasitol Res. 2011 Mar;108(3):541-5. doi: 10.1007/s00436-010-2095-4. Epub 2010 Oct 5. Parasitol Res. 2011. PMID: 20922415 Clinical Trial.
-
Eradication of Blastocystis carriage with antimicrobials: reality or delusion?J Clin Gastroenterol. 2010 Feb;44(2):85-90. doi: 10.1097/MCG.0b013e3181bb86ba. J Clin Gastroenterol. 2010. PMID: 19834337 Review.
-
Is there any reason to continue treating Blastocystis infections?Clin Infect Dis. 1995 Jul;21(1):104-5. doi: 10.1093/clinids/21.1.104. Clin Infect Dis. 1995. PMID: 7578717 Review. No abstract available.
Cited by
-
Distinct Phenotypic Variation of Blastocystis sp. ST3 from Urban and Orang Asli Population-An Influential Consideration during Sample Collection in Surveys.Biology (Basel). 2022 Aug 12;11(8):1211. doi: 10.3390/biology11081211. Biology (Basel). 2022. PMID: 36009838 Free PMC article.
-
The effects of LED Spectra on synthesis of antiparasitic bioactive compound in Eurycoma longifolia hairy root culture against Blastocystis Sp.Sci Rep. 2025 Apr 26;15(1):14662. doi: 10.1038/s41598-025-99906-9. Sci Rep. 2025. PMID: 40287563 Free PMC article.
-
Comparison of apoptotic responses in Blastocystis sp. upon treatment with Tongkat Ali and Metronidazole.Sci Rep. 2021 Apr 9;11(1):7833. doi: 10.1038/s41598-021-81418-x. Sci Rep. 2021. PMID: 33837230 Free PMC article.
-
In vitro susceptibility of human Blastocystis subtypes to simeprevir.Saudi J Biol Sci. 2021 Apr;28(4):2491-2501. doi: 10.1016/j.sjbs.2021.01.050. Epub 2021 Feb 2. Saudi J Biol Sci. 2021. PMID: 33935570 Free PMC article.
-
Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.PLoS One. 2019 Feb 22;14(2):e0212542. doi: 10.1371/journal.pone.0212542. eCollection 2019. PLoS One. 2019. PMID: 30794628 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical